Literature DB >> 19432400

Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells.

Ashley D Reynolds1, David K Stone, R Lee Mosley, Howard E Gendelman.   

Abstract

Microglial inflammatory responses affect Parkinson's disease (PD) associated nigrostriatal degeneration. This is triggered, in measure, by misfolded, nitrated alpha-synuclein (N-alpha-syn) contained within Lewy bodies that are released from dying or dead dopaminergic neurons into the extravascular space. N-alpha-syn-stimulated microglial immunity is regulated by CD4+ T cell subset. Indeed, CD4+CD25+ regulatory T cells (Treg) induce neuroprotective immune responses. This is seen in rodent models of stroke, amyotrophic lateral sclerosis, human immunodeficiency virus associated neurocognitive disorders, and PD. To elucidate the mechanism for Treg-mediated microglial neuroregulatory responses, we used a proteomic platform integrating difference gel electrophoresis and tandem mass spectrometry peptide sequencing. These tests served to determine consequences of Treg on the N-alpha-syn stimulated microglia. The data demonstrated that Treg substantially alter the microglial proteome in response to N-alpha-syn. This is seen through Treg abilities to suppress microglial proteins linked to cell metabolism, migration, protein transport and degradation, redox biology, cytoskeletal, and bioenergetic activities. We conclude that Treg modulate the N-alpha-syn microglial proteome and, in this way, can slow the tempo and course of PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19432400      PMCID: PMC2747638          DOI: 10.1021/pr9001614

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  73 in total

1.  The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.

Authors:  B Mirza; H Hadberg; P Thomsen; T Moos
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 2.  Epidemiology of neurodegeneration.

Authors:  Richard Mayeux
Journal:  Annu Rev Neurosci       Date:  2003-01-24       Impact factor: 12.449

3.  Alterations of T-lymphocyte populations in Parkinson disease.

Authors:  Yasuhiko Baba; Ataru Kuroiwa; Ryan J Uitti; Zbigniew K Wszolek; Tatsuo Yamada
Journal:  Parkinsonism Relat Disord       Date:  2005-09-09       Impact factor: 4.891

4.  Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.

Authors:  Ashley D Reynolds; Rebecca Banerjee; Jianou Liu; Howard E Gendelman; R Lee Mosley
Journal:  J Leukoc Biol       Date:  2007-08-03       Impact factor: 4.962

5.  Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification.

Authors:  Nelson B Cole; Diane Dieuliis; Paul Leo; Drake C Mitchell; Robert L Nussbaum
Journal:  Exp Cell Res       Date:  2008-03-28       Impact factor: 3.905

6.  IFN-gamma and IL-4 differentially shape metabolic responses and neuroprotective phenotype of astrocytes.

Authors:  Sanjay K Garg; Jonathan Kipnis; Ruma Banerjee
Journal:  J Neurochem       Date:  2009-01-07       Impact factor: 5.372

7.  Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease.

Authors:  Edward C Stack; Joellyn L Ferro; Jinho Kim; Steven J Del Signore; Sarah Goodrich; Samantha Matson; Bonnie B Hunt; Kerry Cormier; Karen Smith; Wayne R Matson; Hoon Ryu; Robert J Ferrante
Journal:  Biochim Biophys Acta       Date:  2008-01-16

8.  ATP depletion is the major cause of MPP+ induced dopamine neuronal death and worm lethality in alpha-synuclein transgenic C. elegans.

Authors:  Yi-Min Wang; Pu Pu; Wei-Dong Le
Journal:  Neurosci Bull       Date:  2007-11       Impact factor: 5.203

9.  The effects of aging, injury and disease on microglial function: a case for cellular senescence.

Authors:  Kelly R Miller; Wolfgang J Streit
Journal:  Neuron Glia Biol       Date:  2007-08

10.  Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease.

Authors:  Shaji Theodore; Shuwen Cao; Pamela J McLean; David G Standaert
Journal:  J Neuropathol Exp Neurol       Date:  2008-12       Impact factor: 3.685

View more
  40 in total

1.  Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.

Authors:  Ashley D Reynolds; David K Stone; Jessica A L Hutter; Eric J Benner; R Lee Mosley; Howard E Gendelman
Journal:  J Immunol       Date:  2010-01-29       Impact factor: 5.422

Review 2.  Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases.

Authors:  Lisa M Kosloski; Duy M Ha; Jessica A L Hutter; David K Stone; Michael R Pichler; Ashley D Reynolds; Howard E Gendelman; R Lee Mosley
Journal:  J Neurochem       Date:  2010-05-26       Impact factor: 5.372

3.  A model of nitric oxide induced α-synuclein misfolding in Parkinson's disease.

Authors:  David K Stone; Tomomi Kiyota; R Lee Mosley; Howard E Gendelman
Journal:  Neurosci Lett       Date:  2012-07-07       Impact factor: 3.046

4.  Lymphocytes reduce nigrostriatal deficits in the 6-hydroxydopamine mouse model of Parkinson's disease.

Authors:  Chi Wang Ip; Sandra K Beck; Jens Volkmann
Journal:  J Neural Transm (Vienna)       Date:  2015-08-20       Impact factor: 3.575

Review 5.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 6.  A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.

Authors:  Stephanie D Kraft-Terry; Shilpa J Buch; Howard S Fox; Howard E Gendelman
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

7.  Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms.

Authors:  Weihua Zhao; David R Beers; Bing Liao; Jenny S Henkel; Stanley H Appel
Journal:  Neurobiol Dis       Date:  2012-07-17       Impact factor: 5.996

Review 8.  Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.

Authors:  Li Qian; Patrick M Flood; Jau-Shyong Hong
Journal:  J Neural Transm (Vienna)       Date:  2010-06-23       Impact factor: 3.575

9.  GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice.

Authors:  Lisa M Kosloski; Elizabeth A Kosmacek; Katherine E Olson; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2013-10-29       Impact factor: 3.478

Review 10.  CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease?

Authors:  Kavon Rezai-Zadeh; David Gate; Terrence Town
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.